Sorry, I don't understand your search. ×
Back to Search Start Over

Hepatitis B: The view from West Africa

Authors :
Mario Lepore
Harr F. Njai
Deborah A. Garside
Yusuke Shimakawa
Mary M.E. Crossey
Ramou Njie
Maud Lemoine
Source :
South Sudan Medical Journal, Vol 8, Iss 2, Pp 33-35 (2015)
Publication Year :
2015
Publisher :
Health and Social Sciences Research Institute - South Sudan (HSSRI-SS), 2015.

Abstract

The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study began in 2011 in The Gambia, Sénégal and Nigeria. The study aims to reduce the risk of hepatocellular carcinoma (HCC) in West Africa through the suppression of the Hepatitis B virus (HBV). The biological samples collected allow for the detection of novel liver cancer biomarkers in the hope of improving the diagnostic ability of early disease states. The PROLIFICA platform hopes to improve cancer diagnostics whilst simultaneously providing the training, skills and infrastructure necessary to develop the quality of liver cancer care in West Africa.

Details

Language :
English
ISSN :
23094605 and 23094613
Volume :
8
Issue :
2
Database :
Directory of Open Access Journals
Journal :
South Sudan Medical Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.9d794dba812246bea87b1ebdcf2c0428
Document Type :
article